# Cars.com Inc.: financial statements, quarterly

CARS · NYSE · CIK 1683606 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cars.md) · [Financials](/companies/cars/financials.md) · [Filings](/companies/cars/filings.md) · [Insiders](/companies/cars/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cars/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [174](/filings/0000950170-24-123243.md) | [180 d](/filings/0001193125-26-076546.md) | [180](/filings/0000950170-25-066905.md) | [179](/filings/0001683606-25-000005.md) | [180](/filings/0001193125-25-269472.md) | [180 d](/filings/0001193125-26-076546.md) | [179](/filings/0001193125-26-211864.md) | [179](/filings/0001193125-26-337949.md) | [182](/filings/0001193125-25-269472.md) | [184 d](/filings/0001193125-26-076546.md) | [180](/filings/0001193125-26-211864.md) | [180](/filings/0001193125-26-337949.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [14.3](/filings/0000950170-24-123243.md) | [14.9 d](/filings/0001193125-26-076546.md) | [12.7](/filings/0000950170-25-066905.md) | [9.5](/filings/0001683606-25-000005.md) | [11.5](/filings/0001193125-25-269472.md) | [19.8 d](/filings/0001193125-26-076546.md) | [6.5](/filings/0001193125-26-211864.md) | [15.2](/filings/0001193125-26-337949.md) | [16.8](/filings/0001193125-25-269472.md) | [21.7 d](/filings/0001193125-26-076546.md) | [16.6](/filings/0001193125-26-211864.md) | [27.9](/filings/0001193125-26-337949.md) |
| Income tax | $m | [(1.9)](/filings/0000950170-24-123243.md) | [(6.5) d](/filings/0001193125-26-076546.md) | [0.0](/filings/0000950170-25-066905.md) | [5.0](/filings/0001683606-25-000005.md) | [5.8](/filings/0001193125-25-269472.md) | [2.8 d](/filings/0001193125-26-076546.md) | [0.8](/filings/0001193125-26-211864.md) | [3.0](/filings/0001193125-26-337949.md) | [3.0](/filings/0001193125-25-269472.md) | [7.5 d](/filings/0001193125-26-076546.md) | [3.7](/filings/0001193125-26-211864.md) | [5.3](/filings/0001193125-26-337949.md) |
| Net income | $m | [4.5](/filings/0000950170-24-123243.md) | [8.3 d](/filings/0001193125-26-076546.md) | [0.8](/filings/0001193125-25-269472.md) | [11.4](/filings/0001193125-25-269472.md) | [18.7](/filings/0001193125-25-269472.md) | [17.3 d](/filings/0001193125-26-076546.md) | [(2.0)](/filings/0001193125-26-337949.md) | [7.0](/filings/0001193125-26-337949.md) | [7.7](/filings/0001193125-25-269472.md) | [7.4 d](/filings/0001193125-26-076546.md) | [5.0](/filings/0001193125-26-337949.md) | [14.3](/filings/0001193125-26-337949.md) |
| Diluted EPS | $ per share | [0.07](/filings/0000950170-24-123243.md) | not reported | [0.01](/filings/0000950170-25-066905.md) | [0.17](/filings/0001683606-25-000005.md) | [0.28](/filings/0001193125-25-269472.md) | not reported | [(0.03)](/filings/0001193125-26-211864.md) | [0.11](/filings/0001193125-26-337949.md) | [0.12](/filings/0001193125-25-269472.md) | not reported | [0.08](/filings/0001193125-26-211864.md) | [0.25](/filings/0001193125-26-337949.md) |
| Basic EPS | $ per share | [0.07](/filings/0000950170-24-123243.md) | not reported | [0.01](/filings/0000950170-25-066905.md) | [0.17](/filings/0001683606-25-000005.md) | [0.28](/filings/0001193125-25-269472.md) | not reported | [(0.03)](/filings/0001193125-26-211864.md) | [0.11](/filings/0001193125-26-337949.md) | [0.12](/filings/0001193125-25-269472.md) | not reported | [0.08](/filings/0001193125-26-211864.md) | [0.26](/filings/0001193125-26-337949.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [49.1](/filings/0000950170-23-058163.md) | [39.2](/filings/0000950170-25-029023.md) | [31.4](/filings/0000950170-24-056894.md) | [29.1](/filings/0000950170-24-093890.md) | [49.6](/filings/0000950170-24-123243.md) | [50.7](/filings/0001193125-26-076546.md) | [31.4](/filings/0000950170-25-066905.md) | [27.7](/filings/0001683606-25-000005.md) | [55.1](/filings/0001193125-25-269472.md) | [56.2](/filings/0001193125-26-337949.md) | [64.6](/filings/0001193125-26-211864.md) | [33.3](/filings/0001193125-26-337949.md) |
| Current assets | $m | [189](/filings/0000950170-23-058163.md) | [178](/filings/0000950170-25-029023.md) | [177](/filings/0000950170-24-056894.md) | [178](/filings/0000950170-24-093890.md) | [200](/filings/0000950170-24-123243.md) | [214](/filings/0001193125-26-076546.md) | [183](/filings/0000950170-25-066905.md) | [180](/filings/0001683606-25-000005.md) | [212](/filings/0001193125-25-269472.md) | [212](/filings/0001193125-26-337949.md) | [218](/filings/0001193125-26-211864.md) | [195](/filings/0001193125-26-337949.md) |
| Total assets | $m | [1,103](/filings/0000950170-23-058163.md) | [1,172](/filings/0000950170-25-029023.md) | [1,143](/filings/0000950170-24-056894.md) | [1,121](/filings/0000950170-24-093890.md) | [1,119](/filings/0000950170-24-123243.md) | [1,112](/filings/0001193125-26-076546.md) | [1,084](/filings/0000950170-25-066905.md) | [1,065](/filings/0001683606-25-000005.md) | [1,071](/filings/0001193125-25-269472.md) | [1,062](/filings/0001193125-26-337949.md) | [1,053](/filings/0001193125-26-211864.md) | [1,012](/filings/0001193125-26-337949.md) |
| Current liabilities | $m | [131](/filings/0000950170-23-058163.md) | [146](/filings/0000950170-25-029023.md) | [109](/filings/0000950170-24-056894.md) | [117](/filings/0000950170-24-093890.md) | [111](/filings/0000950170-24-123243.md) | [117](/filings/0001193125-26-076546.md) | [111](/filings/0000950170-25-066905.md) | [98.9](/filings/0001683606-25-000005.md) | [117](/filings/0001193125-25-269472.md) | [113](/filings/0001193125-26-337949.md) | [117](/filings/0001193125-26-211864.md) | [97.6](/filings/0001193125-26-337949.md) |
| Total liabilities | $m | [620](/filings/0000950170-23-058163.md) | [680](/filings/0000950170-25-029023.md) | [662](/filings/0000950170-24-056894.md) | [624](/filings/0000950170-24-093890.md) | [616](/filings/0000950170-24-123243.md) | [600](/filings/0001193125-26-076546.md) | [594](/filings/0000950170-25-066905.md) | [581](/filings/0001683606-25-000005.md) | [594](/filings/0001193125-25-269472.md) | [590](/filings/0001193125-26-337949.md) | [593](/filings/0001193125-26-211864.md) | [569](/filings/0001193125-26-337949.md) |
| Long-term debt | $m | [430](/filings/0000950170-23-058163.md) | [460](/filings/0000950170-25-029023.md) | [474](/filings/0000950170-24-056894.md) | [470](/filings/0000950170-24-093890.md) | [465](/filings/0000950170-24-123243.md) | [455](/filings/0001193125-26-076546.md) | [456](/filings/0000950170-25-066905.md) | [456](/filings/0001683606-25-000005.md) | [451](/filings/0001193125-25-269472.md) | [452](/filings/0001193125-26-337949.md) | [452](/filings/0001193125-26-211864.md) | [447](/filings/0001193125-26-337949.md) |
| Current portion of debt | $m | [18.1](/filings/0000950170-23-058163.md) | [23.1](/filings/0000950170-25-029023.md) | [0.0](/filings/0000950170-24-056894.md) | [0.0](/filings/0000950170-24-093890.md) | [0.0](/filings/0000950170-24-123243.md) | [0.0](/filings/0000950170-25-029023.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [483](/filings/0000950170-24-123243.md) | [492](/filings/0001193125-26-076546.md) | [481](/filings/0001193125-25-269472.md) | [497](/filings/0001193125-25-269472.md) | [502](/filings/0001193125-25-269472.md) | [511](/filings/0001193125-26-337949.md) | [490](/filings/0001193125-26-337949.md) | [483](/filings/0001193125-26-337949.md) | [478](/filings/0001193125-25-269472.md) | [473](/filings/0001193125-26-337949.md) | [461](/filings/0001193125-26-337949.md) | [444](/filings/0001193125-26-337949.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [35.4 d](/filings/0000950170-24-123243.md) | [45.1 d](/filings/0001193125-26-076546.md) | [33.5](/filings/0000950170-25-066905.md) | [35.3 d](/filings/0001683606-25-000005.md) | [53.8 d](/filings/0001193125-25-269472.md) | [30.0 d](/filings/0001193125-26-076546.md) | [29.5](/filings/0001193125-26-211864.md) | [26.2 d](/filings/0001193125-26-337949.md) | [58.8 d](/filings/0001193125-25-269472.md) | [37.1 d](/filings/0001193125-26-076546.md) | [39.8](/filings/0001193125-26-211864.md) | [15.8 d](/filings/0001193125-26-337949.md) |
| Capital expenditure | $m | [0.2 d](/filings/0000950170-24-123243.md) | [0.5 d](/filings/0001193125-26-076546.md) | [0.7](/filings/0000950170-25-066905.md) | [0.4 d](/filings/0001683606-25-000005.md) | [0.9 d](/filings/0001193125-25-269472.md) | [1.0 d](/filings/0001193125-26-076546.md) | [0.8](/filings/0001193125-26-211864.md) | [2.5 d](/filings/0001193125-26-337949.md) | [0.6 d](/filings/0001193125-25-269472.md) | [0.4 d](/filings/0001193125-26-076546.md) | [0.3](/filings/0001193125-26-211864.md) | [0.5 d](/filings/0001193125-26-337949.md) |
| Share repurchases | $m | [6.2 d](/filings/0000950170-24-123243.md) | [8.0 d](/filings/0001193125-26-076546.md) | [9.1](/filings/0000950170-25-066905.md) | [5.3 d](/filings/0001683606-25-000005.md) | [21.3 d](/filings/0001193125-25-269472.md) | [13.5 d](/filings/0001193125-26-076546.md) | [21.5](/filings/0001193125-26-211864.md) | [23.1 d](/filings/0001193125-26-337949.md) | [19.7 d](/filings/0001193125-25-269472.md) | [22.6 d](/filings/0001193125-26-076546.md) | [20.5](/filings/0001193125-26-211864.md) | [37.0 d](/filings/0001193125-26-337949.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [67.7](/filings/0000950170-23-058163.md) | [67.7](/filings/0000950170-24-056894.md) | [68.5](/filings/0000950170-24-093890.md) | [68.5](/filings/0000950170-24-123243.md) | [67.3](/filings/0000950170-25-066905.md) | [67.8](/filings/0001683606-25-000005.md) | [67.7](/filings/0001193125-25-269472.md) | [64.5](/filings/0001193125-26-211864.md) | [63.8](/filings/0001193125-26-337949.md) | [63.1](/filings/0001193125-25-269472.md) | [59.6](/filings/0001193125-26-211864.md) | [56.7](/filings/0001193125-26-337949.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 53,532,714 at 2026-08-03, from the cover of the [10-Q filed 2026-08-06](/filings/0001193125-26-337949.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.
